MLB Injuries Today: Braves Lean on Lopez for 2026 Season
MLB injuries today have cracked Atlanta’s 2026 rotation wide open, with three projected starters sidelined by elbow surgery before the regular season begins. Reynaldo Lopez — the All-Star right-hander who posted a 1.99 ERA — now carries the staff on his own recovering shoulder.
Kerry Miller of Bleacher Report named Lopez the Braves’ X-factor for 2026, a label grounded in hard roster math. AJ Smith-Shawver, Spencer Schwellenbach, and Hurston Waldrep are all recovering from elbow procedures. None are expected back before mid-summer, per Miller’s reporting. That is three arms stripped from the opening-day staff, and Atlanta’s NL East standing through the first two months hinges on how Lopez performs.
How Atlanta’s Rotation Reached This Breaking Point
MLB injuries today rarely arrive in isolation, but Atlanta’s situation is unusually concentrated. Smith-Shawver, Schwellenbach, and Waldrep each represent a different development tier — one established arm, one ascending, one still proving himself — yet all three share the same diagnosis: elbow surgery with an extended recovery window.
Losing one starter would stress any staff. Losing all three at once is a structural problem that demands an immediate answer. The Braves posted a team ERA of 3.86 in 2024, ranking among the better pitching staffs in the National League. Stripping three contributors from that foundation before April forces replacement-level arms into high-leverage roles far earlier than any front office would choose.
Stay in the game
Get the latest MLB news and analysis delivered to your inbox.
Those replacement options typically carry higher walk rates and weaker platoon splits against left-handed hitters. The Braves face the Philadelphia Phillies and New York Mets repeatedly in the first half — two of the most disciplined lineups in the division. Lopez must absorb innings at a rate that limits exposure of Atlanta’s back-end arms during those matchups.
MLB injuries at the rotation level carry a compounding cost that raw standings do not capture quickly. Every extra inning the bullpen absorbs in April is an inning unavailable in September, when leverage peaks and roster depth thins. Atlanta’s front office understands this arithmetic, which is why Lopez’s health is being treated as the franchise’s first-half foundation stone.
Lopez’s 1.99 ERA earned him All-Star recognition and placed him among the elite arms in the American League. That figure is not a small-sample outlier. Lopez rebuilt his profile around a sharper release point, improved zone command, and a willingness to attack hitters with his fastball in counts where most pitchers retreat to offspeed.
His strikeout-to-walk ratio climbed in each of the three seasons before his injury. That metric is the single most predictive indicator of a pitcher’s ability to sustain performance through mechanical disruption. A strong K/BB ratio means a pitcher can still generate outs even when his raw stuff plays down slightly. That profile is exactly what Atlanta needs from a returning arm navigating a compressed workload in 2026.
Shoulder surgeries carry a longer and less predictable recovery arc than elbow procedures. The shoulder’s range of motion demands stress on multiple muscle groups at once. Based on documented outcomes from pitchers who returned from comparable procedures, velocity typically drops two to four mph in the first full season back. Spin rate follows a similar curve before stabilizing in year two. Even a 3.20-to-3.50 FIP version of Lopez would rank as one of Atlanta’s two or three most valuable starters given the current depth gap.
The data also shows that pitchers with Lopez’s command profile — those who walk fewer than 2.2 batters per nine innings — tend to limit damage even when velocity dips. Lopez averaged 1.9 BB/9 in his peak season. That figure suggests his floor is higher than the raw injury risk implies.
Key Developments in Atlanta’s MLB Injury Situation
To understand the full scope of what Atlanta faces, consider each injury in sequence. AJ Smith-Shawver is recovering from elbow surgery and is not expected back before June 2026, removing a rotation piece from the entire first half. Spencer Schwellenbach, one of Atlanta’s most closely watched young starters, faces the same procedure and a comparable return timeline. Hurston Waldrep joins both of them on the shelf, making three projected starters unavailable simultaneously.
Reynaldo Lopez is identified by Bleacher Report’s Kerry Miller as Atlanta’s X-factor for 2026, given the void left by those three injuries. Lopez is coming off major shoulder surgery, adding a layer of uncertainty to Atlanta’s plans even as he is expected to anchor the staff through the early months.
Together, these five facts form a clear picture: Atlanta enters 2026 with its rotation depth depleted at every tier, from proven starter to developmental arm, and with its presumed ace carrying his own medical question mark. The Braves’ front office must navigate that reality from the first day of the regular season.
What Atlanta’s Injury Crisis Means for the NL East Race
The Philadelphia Phillies won 95-plus games in back-to-back seasons and enter 2026 with a deeper, healthier rotation. The New York Mets added pitching depth across the offseason. The Braves, by contrast, are asking a post-surgery All-Star to anchor a staff missing three arms for roughly two months. That gap in rotation depth translates directly into projected win totals.
Atlanta’s roster moves between now and the summer return window will define whether the club stays within striking distance of the division lead or falls into a deficit too large to close. Waiver wire additions, minor-league call-ups, and trade deadline strategy all connect back to Lopez’s performance in the interim.
If Lopez’s shoulder holds and his ERA stays below 3.50 through May, Atlanta’s front office gains time and leverage. If he struggles or suffers a setback, the Braves face a steeper climb even after Smith-Shawver, Schwellenbach, and Waldrep return.
One counterpoint: Atlanta’s lineup — Ronald Acuña Jr., Matt Olson, and Ozzie Albies when healthy — carries enough offensive depth to outscore opponents on nights when pitching wavers. The offensive WAR projection for that core, based on recent season data, supports the idea that the Braves can win through run production if Lopez is sharp. But a lineup-dependent strategy across 162 games is a fragile one. Atlanta’s long-term pitching development plan points toward rotation depth as the franchise’s priority, and MLB injuries today have forced that priority into sharp, uncomfortable focus.
Which Braves pitchers are injured heading into the 2026 MLB season?
AJ Smith-Shawver, Spencer Schwellenbach, and Hurston Waldrep are all recovering from elbow surgeries. Their returns are not expected before June 2026, according to Bleacher Report’s Kerry Miller. All three were projected rotation contributors before their injuries were confirmed.
What is Reynaldo Lopez’s ERA and why does it matter for Atlanta?
Reynaldo Lopez posted a 1.99 ERA in his All-Star season, placing him among the most effective pitchers in the game during that stretch. With three Braves starters sidelined by elbow surgery, Lopez is Atlanta’s primary rotation anchor through the first half of 2026.
Is Reynaldo Lopez fully healthy after shoulder surgery?
Lopez is coming off major shoulder surgery and his full health status carries real uncertainty heading into 2026. Pitchers returning from shoulder procedures typically see velocity drop two to four mph in their first full season back, though Lopez’s strong command profile may help offset those effects.
How do MLB injuries today affect Atlanta’s NL East chances?
Losing three rotation starters for roughly two months puts the Braves at a measurable disadvantage against the Phillies and Mets, both of whom enter 2026 with deeper pitching staffs. Atlanta’s ability to stay competitive through the first half depends heavily on Lopez’s performance and health.
When will Smith-Shawver, Schwellenbach, and Waldrep return from injury?
All three Braves pitchers are progressing through individual rehabilitation programs after elbow surgeries, per Bleacher Report’s Kerry Miller. Their exact return dates remain fluid, though none are projected to be active before the midpoint of the 2026 season.
